Head-to-head · WeighScore
EdgeRx vs Elara MD
The verdict
EdgeRx takes it — 79/100 to 53.5/100.
EdgeRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A men's-only compounded GLP-1 program that names its pharmacy (Strive Pharmacy, 503A since 2018) and its Chief Medical Advisor — real transparency signals most compounders skip.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | EdgeRx | Elara MD |
|---|---|---|
| WeighScore | 79/100 | 53.5/100 |
| Grade | C+ | C |
| Scorecard rank | #43 | #507 |
| Semaglutide | $229/mo | $249/mo (0.2 mg dose, compounded) |
| Tirzepatide | $299/mo | $349/mo (2.0 mg dose, compounded) |
| Coverage | 46 states (excludes Arkansas, Indiana, Minnesota, South Carolina) | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #43 · C+
Strengths
- Named compounding pharmacy — Strive Pharmacy, a 503A facility compounding since 2018 — a genuine transparency signal most compounders lack
- Named Chief Medical Advisor, Dr. John Starke, MD (ABEM board-certified)
- LegitScript certified, once-weekly injectable, free shipping, no separate physician fee
- Broad protocol menu beyond GLP-1 — MICC lipotropic, sermorelin/NAD+/glutathione, skin/hair, and sexual/hormonal health tiers
Where it loses points
- Men's-only positioning — not an option for women
- Dr. Starke does not personally prescribe; the actual prescribing pool is unnamed licensed physicians
- Third-party lab testing is claimed but no specific lab is named
- Excludes Arkansas, Indiana, Minnesota and South Carolina (46 states)
- Bloodwork cost is undisclosed on the Sexual & Hormonal Health tier
Graded #507 · C
Strengths
- Dose-banded monthly pricing published on-site ($249–$649/mo across tiers)
- Both a semaglutide-range and a tirzepatide-range (GLP-1/GIP) option, plus microdosing
- Medication included in the monthly price with free fast shipping when prescribed
- Broad reach claimed (over 40 states)
Where it loses points
- Molecules not named on-site (only 'Personalized GLP-1') — compounded status is inferred
- No FDA compounded-medication disclaimer published
- No named compounding pharmacy partner — prescriptions are patient-directed
- LegitScript certification, medical director, and full state list not disclosed
- Pricier than several compounded competitors
Also worth a look
Another provider to compare: CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.